Chapter 6 116 References 1. Siddiqui MRS, Gormly KL, Bhoday J, et al. Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG). Clin Radiol. 2016;71:854–862. 2. Patel UB, Taylor F, Blomqvist L, et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol. 2011;29:3753–3760. 3. Sclafani F, BrownG, CunninghamD, et al. ComparisonbetweenMRI andpathology in theassessment of tumour regression grade in rectal cancer. Br J Cancer. 2017;117:1478–1485. 4. Bosman SJ, Holman FA, Nieuwenhuijzen GAP, et al. Feasibility of reirradiation in the treatment of locally recurrent rectal cancer. Br J Surg. 2014;101:1280–1289. 5. Van Der Meij W, Rombouts AJM, Rutten H, et al. Treatment of Locally Recurrent Rectal Carcinoma in Previously (Chemo)Irradiated Patients: A Review. Dis Colon Rectum. 2016;59:148–156. 6. NielsenMB, Laurberg S, HolmT. Current management of locally recurrent rectal cancer. Colorectal Disease. 2011;13:732–742. 7. Vermaas M, Ferenschild F, Verhoef C, et al. Pre-operative radiotherapy improves outcome of multimodality treatment in recurrent rectal cancer. Ann Surg Oncol. 2006;11:S108–S108. 8. Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv22–iv40. 9. Alberda WJ, Verhoef C, Schipper MEI, et al. The Importance of a Minimal Tumor-Free Resection Margin in Locally Recurrent Rectal Cancer. Dis Colon Rectum. 2015;58:677–685. 10. NielsenM, RasmussenP, PedersenB, et al. Early andLateOutcomes of Surgery for LocallyRecurrent Rectal Cancer: A Prospective 10-Year Study in the Total Mesorectal Excision Era. Ann Surg Oncol. 2015;22:2677–2684. 11. Westberg K, Palmer G, Hjern F, et al. Management and prognosis of locally recurrent rectal cancer – A national population-based study. Eur J Surg Oncol. 2018;44:100–107. 12. van Zoggel DMGI, Bosman SJ, Kusters M, et al. Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer. Br J Surg. 2018;105:447–452. 13. Voogt ELK, vanZoggel DMGI, KustersM, et al. ImprovedOutcomes for Responders After Treatment with Induction Chemotherapy and Chemo(re)irradiation for Locally Recurrent Rectal Cancer. Ann Surg Oncol. 2020;8–11. 14. Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994;73:2680–6. 15. GlynT, Frizelle F. Quality of life outcomes in patients undergoing surgery for locally recurrent rectal cancer. Semin Colon Rectal Surg.;31 . Epub ahead of print 2020. DOI: 10.1016/j.scrs.2020.100767. 16. Esnaola NF, Cantor SB, Johnson ML, et al. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol. 2002;20:4361–4367. 17. Lambregts DMJ, Boellaard TN, Beets-Tan RGH. Response evaluation after neoadjuvant treatment for rectal cancer using modern MR imaging: a pictorial review. Insights Imaging. 2019;10:15. 18. Habr-Gama A, Perez RO, Wynn G, et al. Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: Characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum. 2010;53:1692–1698.
RkJQdWJsaXNoZXIy MTk4NDMw